Novel compounds for plant disease control
Nucleic Acid-, Protein and Cell-related Technologies : Protein related
Green Biotech
Ref.-No.: 0707-5356-MG
Technology
Scientists from the Max-Planck-Institutes for Multidisciplinary Sciences and Plant Breeding Research have identified compounds for treatment and protection of plant diseases caused by fungi, oomycetes and bacteria with high functionality and expected low toxicity.
Plant pathogens produce self-aggregating proteins similar to amyloid proteins, that contribute to extracellular structures such as cell walls, adhesion structures to biological surfaces and other pathogenicity related infection structures such as biofilmes. Our scientists have found and characterized compounds that inhibit protein aggregation of amyloid-like proteins, that had significant effects on the growth of plant pathogens.
These compounds are unlikely to induce plant resistance to pathogen but target the pathogen directly, are expected to show low human toxicity and high substance specificity with a low probability to develop resistances and are therefore highly suitable as novel pesticides for the protection of plant diseases.
We are now looking for a collaboration partner to further develop this exciting project.
Patent Information
An EP priority application was filed on 27.10.2021.
PDF Download
- Ref.-No.: 0707-5356-MG (144.9 KiB)
Contact

Senior Patent- & License Manager
Dr. Mareike Göritz
Chemist
Phone: +49 89 / 29 09 19-32
Email:
goeritz@max-planck-innovation.de